Recently, CF PharmTech (hereinafter referred to as "CF") has received the approval document from the overseas regulatory authority and successfully passed the overseas GMP (Good Manufacturing Practice) on-site inspection.

In December 2024, the company underwent a multi-day on-site audit conducted by an overseas expert team. Attaching great importance to this audit, CF fully complied with the audit requirements of the regulatory authority, and conducted in-depth demonstrations and in-depth exchanges on aspects such as the company's quality management system, product production processes, and quality control. The overseas expert inspection team highly recognized the company's performance in these areas.

As always, CF regards product quality as the "lifeline" of its development. The company has built production workshops that meet international standards, established a quality management system based on high standards, and consistently maintained strict quality supervision requirements, embedding quality culture into its daily operations. Meanwhile, the company organizes a special "Quality Month" activity every year to enhance employees' quality awareness, promote the construction of the quality management system, and drive the continuous improvement of the quality system. The successful passing of this on-site audit by the overseas regulatory authority marks that the company's production and quality management has been recognized by authoritative overseas institutions, providing strong support for the company's future expansion in the international market.

Adhering to a globalization strategy, CF is committed to expanding the international market and has established cooperative relationships with customers in various regions around the world. In the future, the company will always uphold the philosophy of "taking patients' practical clinical needs as its responsibility, exploring, developing and providing inhaled preparations with reliable quality". It will continuously improve its quality management level, enhance patients' quality of life, and make sustained contributions to the cause of human health!